Nichol Ochsner | Vice President of Investor Relations |
Robert Finizio | Chief Executive Officer |
Daniel Cartwright | Chief Financial Officer |
Brian Bernick | Co-Founder & Director |
Dawn Halkuff | Chief Commercial Officer |
Ken Cacciatore | Cowan & Co. |
Louise Chen | Cantor Fitzgerald |
Annabel Samimy | Stifel |
Jay Olson | Oppenheimer |
Chris Schott | JPMorgan |
Michael Scott | Goldman Sachs |
Good afternoon, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD's Fourth Quarter and Full Year 2018 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions.
As a reminder, today’s call is being recorded. I would now like to turn the call over to Therapeutics’ Vice President of Investor Relations, Nichol Ochsner.